TSX-V:PINK • CA71385D1078
The current stock price of PINK.CA is 0.3 CAD. In the past month the price decreased by -11.76%. In the past year, price decreased by -48.28%.
ChartMill assigns a technical rating of 4 / 10 to PINK.CA. When comparing the yearly performance of all stocks, PINK.CA turns out to be only a medium performer in the overall market: it outperformed 40.69% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to PINK.CA. Both the profitability and financial health of PINK.CA have multiple concerns.
Over the last trailing twelve months PINK.CA reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS increased by 36.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -239.48% | ||
| ROE | -412.07% | ||
| Debt/Equity | 0.02 |
5 analysts have analysed PINK.CA and the average price target is 1.89 CAD. This implies a price increase of 529% is expected in the next year compared to the current price of 0.3.
For the next year, analysts expect an EPS growth of 21.56% and a revenue growth 244.83% for PINK.CA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 322.981M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 77.118M | ||
| MIR | MEDMIRA INC | N/A | 53.082M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 43.436M | ||
| ASG | AURORA SPINE CORP | N/A | 22.394M | ||
| VPT | VENTRIPOINT DIAGNOSTICS LTD | N/A | 22.364M | ||
| NSCI | NANALYSIS SCIENTIFIC CORP | N/A | 22.152M | ||
| MDX | MEDX HEALTH CORP | N/A | 18.036M | ||
| THRM | THERMA BRIGHT INC | N/A | 3.125M |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find more growth stocks the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Perimeter Medical Imaging AI, Inc. is a medical technology company, which develops, patents and commercializes surgical imaging tools. The company is headquartered in Toronto, Ontario and currently employs 58 full-time employees. The Company’s Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures. The OCT imaging system includes an intraoperative device for automated scanning of the specimen that provides a rapid subsurface map of up to 10 centimeters (cm) by 10 cm surface area; a specimen-handling consumable designed to hold and maintain orientation of the specimen, and an image library and training set. Its S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The company is focused on its machine learning tools and artificial intelligence (AI) technology, called ImgAssist AI, through clinical development under its ATLAS AI project.
PERIMETER MEDICAL IMAGING AI
555 Richmond Street W., Suite 511
TORONTO ONTARIO M5E 1E6 CA
CEO: Jeremy Sobotta
Employees: 43
Phone: 18889887465
Perimeter Medical Imaging AI, Inc. is a medical technology company, which develops, patents and commercializes surgical imaging tools. The company is headquartered in Toronto, Ontario and currently employs 58 full-time employees. The Company’s Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures. The OCT imaging system includes an intraoperative device for automated scanning of the specimen that provides a rapid subsurface map of up to 10 centimeters (cm) by 10 cm surface area; a specimen-handling consumable designed to hold and maintain orientation of the specimen, and an image library and training set. Its S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The company is focused on its machine learning tools and artificial intelligence (AI) technology, called ImgAssist AI, through clinical development under its ATLAS AI project.
The current stock price of PINK.CA is 0.3 CAD. The price increased by 5.26% in the last trading session.
PINK.CA does not pay a dividend.
PINK.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
PINK.CA stock is listed on the TSX Venture Exchange exchange.
PERIMETER MEDICAL IMAGING AI (PINK.CA) will report earnings on 2026-03-24, after the market close.